Computational modeling of the p7 monomer from HCV and its interaction with small molecule drugs

Yi Ting Wang, Hao Jen Hsu, Wolfgang B. Fischer

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Hepatitis C virus p7 protein is a 63 amino acid polytopic protein with two transmembrane domains (TMDs) and one of the prime targets for anti HCV drug development. A bio-inspired modeling pathway is used to generate plausible computational models of the two TMDs forming the monomeric protein model. A flexible region between Leu-13 and Gly-15 is identified for TMD11-32 and a region around Gly-46 to Trp-48 for TMD236-58. Mutations of the tyrosine residues in TMD236-58 into phenylalanine and serine are simulated to identify their role in shaping TMD2. Lowest energy structures of the two TMDs connected with the loop residues are used for a posing study in which small molecule drugs BIT225, amantadine, rimantadine and NN-DNJ, are identified to bind to the loop region. BIT225 is identified to interact with the backbone of the functionally important residues Arg-35 and Trp-36.

Original languageEnglish
Article number324
Pages (from-to)1-14
Number of pages14
Issue number1
StatePublished - 2013


  • Docking approach
  • HCV
  • Ion channels
  • Membrane protein
  • Molecular dynamics simulations
  • p7 protein


Dive into the research topics of 'Computational modeling of the p7 monomer from HCV and its interaction with small molecule drugs'. Together they form a unique fingerprint.

Cite this